Contreras Jaime 4

4 · ABBOTT LABORATORIES · Filed Feb 25, 2020

Form 4

Period: 2020-02-21

Senior Vice President

Transactions

Award
Common shares without par value
2020-02-21+11,250→ 45,956 total
Award
Option (right to buy)
2020-02-21+68,578→ 68,578 total
Exercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (68,578 underlying)

Holdings

Footnotes (7)

[F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
[F2]On May 10, 2019, the reporting person transferred 22,898 directly owned shares to the Jaime Contreras Marvan 2006 Living Trust.
[F3]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2020.
[F4]Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
[F5]The reporting person disclaims beneficial ownership of all securities held by his spouse.
[F6]Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The Trust is revocable. The reporting person disclaims beneficial ownership of these securities.
[F7]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,859 on February 21, 2021, 22,859 on February 21, 2022, and 22,860 on February 21, 2023.

Documents

1 file